Company / Gross Profit
UTAH MEDICAL PRODUCTS INC Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$30.0M
FY2025
5-year range
$6.8M / $32.2M
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 10 years, ranging from $7M in FY2022 to $32M in FY2024.
Based on SEC 10-K filings.
$30M in FY2025 with a 5-year CAGR of +2.7%.
Declined from $31M to $30M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +63.8%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.7%, indicating consistent growth.
- In FY2025, gross profit decreased 6.7% year-over-year.
- Peak gross profit was recorded in FY2024.
- Lowest gross profit in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.0M | -6.7% |
| FY2024 | $32.2M | +4.1% |
| FY2023 | $30.9M | +352.3% |
| FY2022 | $6.8M | -76.8% |
| FY2021 | $29.5M | +12.0% |
| FY2020 | $26.3M | -0.3% |
| FY2019 | $26.4M | +11.4% |
| FY2018 | $23.7M | -2.0% |
| FY2017 | $24.2M | -3.2% |
| FY2016 | $25.0M | +2.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026